These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 29223374

  • 1. Cardiac Involvement in a Patient Cohort With Val30Met Mutation Transthyretin Amyloidosis.
    Ripoll-Vera T, Buades J, Cisneros E, Gómez Y, Núñez J, Raya M.
    Rev Esp Cardiol (Engl Ed); 2019 Jan; 72(1):92-94. PubMed ID: 29223374
    [No Abstract] [Full Text] [Related]

  • 2. Transthyretin Cardiac Amyloidosis Due to Homozygous Val122Ile Mutation in a Caucasian Man.
    Marrero Negrín N, Medina Gil JM, García Cruz ML, Jiménez Cabrera F.
    Rev Esp Cardiol (Engl Ed); 2019 Dec; 72(12):1086-1088. PubMed ID: 31561982
    [No Abstract] [Full Text] [Related]

  • 3. Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey).
    Maurer MS, Hanna M, Grogan M, Dispenzieri A, Witteles R, Drachman B, Judge DP, Lenihan DJ, Gottlieb SS, Shah SJ, Steidley DE, Ventura H, Murali S, Silver MA, Jacoby D, Fedson S, Hummel SL, Kristen AV, Damy T, Planté-Bordeneuve V, Coelho T, Mundayat R, Suhr OB, Waddington Cruz M, Rapezzi C, THAOS Investigators.
    J Am Coll Cardiol; 2016 Jul 12; 68(2):161-72. PubMed ID: 27386769
    [Abstract] [Full Text] [Related]

  • 4. Wild-type transthyretin significantly contributes to the formation of amyloid fibrils in familial amyloid polyneuropathy patients with amyloidogenic transthyretin Val30Met.
    Tsuchiya-Suzuki A, Yazaki M, Kametani F, Sekijima Y, Ikeda S.
    Hum Pathol; 2011 Feb 12; 42(2):236-43. PubMed ID: 21056899
    [Abstract] [Full Text] [Related]

  • 5. Non-Val30Met mutation, septal hypertrophy, and cardiac denervation in patients with mutant transthyretin amyloidosis.
    Hirakawa K, Takashio S, Marume K, Yamamoto M, Hanatani S, Yamamoto E, Sakamoto K, Izumiya Y, Kaikita K, Oda S, Utsunomiya D, Shiraishi S, Ueda M, Yamashita T, Yamashita Y, Ando Y, Tsujita K.
    ESC Heart Fail; 2019 Feb 12; 6(1):122-130. PubMed ID: 30284755
    [Abstract] [Full Text] [Related]

  • 6. Effect of doxycycline and ursodeoxycholic acid on transthyretin amyloidosis.
    Wixner J, Pilebro B, Lundgren HE, Olsson M, Anan I.
    Amyloid; 2017 Mar 12; 24(sup1):78-79. PubMed ID: 28042702
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Disease-Modifying Treatments for Transthyretin Amyloidosis.
    Tushak ZJ, Cox SZ, Cei LF, Gwathmey KG, Shah KB.
    J Cardiovasc Pharmacol; 2021 Nov 01; 78(5):e641-e647. PubMed ID: 34321398
    [Abstract] [Full Text] [Related]

  • 9. Transthyretin deposition in familial amyloidotic polyneuropathy.
    Saraiva MJ, Magalhaes J, Ferreira N, Almeida MR.
    Curr Med Chem; 2012 Nov 01; 19(15):2304-11. PubMed ID: 22471982
    [Abstract] [Full Text] [Related]

  • 10. Amyloid Cardiomyopathy in the Rare Transthyretin Tyr78Phe Mutation.
    Tini G, Vianello PF, Gemelli C, Grandis M, Canepa M.
    J Cardiovasc Transl Res; 2019 Dec 01; 12(6):514-516. PubMed ID: 30604309
    [Abstract] [Full Text] [Related]

  • 11. Amyloidogenic transthyretin Val30Met homozygote showing unusually early-onset familial amyloid polyneuropathy.
    Tojo K, Sekijima Y, Machida K, Tsuchiya A, Yazaki M, Ikeda S.
    Muscle Nerve; 2008 Jun 01; 37(6):796-803. PubMed ID: 18506713
    [Abstract] [Full Text] [Related]

  • 12. V122I Transthyretin Cardiomyopathy: An Opportunity to Build Trust and Resolve Disparities.
    Sher T, Velarde GP, Gertz MA.
    J Am Coll Cardiol; 2020 Jul 07; 76(1):93-95. PubMed ID: 32616166
    [No Abstract] [Full Text] [Related]

  • 13. Assessment of transthyretin instability in patients with wild-type transthyretin amyloid cardiomyopathy.
    Iino T, Nagao M, Tanaka H, Yoshikawa S, Asakura J, Nishimori M, Shinohara M, Harada A, Watanabe S, Ishida T, Hirata KI, Toh R.
    Sci Rep; 2024 Sep 03; 14(1):20508. PubMed ID: 39227655
    [Abstract] [Full Text] [Related]

  • 14. Amyloid fibril composition within hereditary Val30Met (p. Val50Met) transthyretin amyloidosis families.
    Suhr OB, Wixner J, Anan I, Lundgren HE, Wijayatunga P, Westermark P, Ihse E.
    PLoS One; 2019 Sep 03; 14(2):e0211983. PubMed ID: 30811423
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A machine learning model for identifying patients at risk for wild-type transthyretin amyloid cardiomyopathy.
    Huda A, Castaño A, Niyogi A, Schumacher J, Stewart M, Bruno M, Hu M, Ahmad FS, Deo RC, Shah SJ.
    Nat Commun; 2021 May 11; 12(1):2725. PubMed ID: 33976166
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.